Seminar Series: An Update on the Latest CFDA Deepening Regulatory Reform

Start Date & Time: 
Tuesday, 17 July, 2018 - 15:30
End Date & Time: 
Tuesday, 17 July, 2018 - 17:00

Amphitheatre, Duke-NUS Medical School

Speaker Details: 
Ms Vicky Han
Senior Director
Policy Group Lead for Asia Pacific
Global Regulatory Affairs
Janssen Asia Pacific
Following up on CoRE’s previous Seminar Series on regulatory developments in China, the China Food and Drug Administration (CFDA) has since met all of its objectives to initiate reforms to its regulatory frameworks in 2017. This resulted in a reduction of lag time, increase in regulatory capacity and the implementation of a science-based regulatory review approach. To further improve China’s regulatory environment, the Deepening Reform was implemented in October 2017 which has resulted in the publication of various new guidelines, regulations and requirements. In light of these rapid and successive changes, this seminar examines the key reforms and their impact on the global regulatory environment in the near future. 
Prof John Lim
Executive Director, CoRE
Duke-NUS Medical School &
Senior Adviser
Ministry of Health, Singapore 
Other Information: 
Registration Fee: 
Standard - $50
Contact Person: 
Sherna Wadia